ArticleAmerican journal of cancer research2023

Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.

Wei-Fan Hsu et al.PubMed ↗Full text ↗

No numbers read from the abstract.